Showing results (41-50 of 663) with videos related to
Sort By:
Pageof 67
Molecular Pharmacology|July 1, 1983
Forskolin does not activate sperm adenylate cyclaseL R Forte, D B Bylund, W L ZahlerJournal of Neurochemistry|February 1, 1982
Alterations in neurotransmitter receptor binding in discrete areas of the copper-deficient rat brainD J Feller, B L O'Dell, D B BylundLife Sciences|September 24, 1984
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-ECJ T Turner, D L Pierce, D B BylundAlcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1987
Reduction of rat pineal N-acetyltransferase activity by fetal alcohol exposureP K Rudeen, D B Bylund, C A KappelAnesthesiology|November 1, 1992
Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cordR G Lawhead, H S Blaxall, D B BylundMolecular Pharmacology|November 1, 1985
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclaseJ T Turner, C Ray-Prenger, D B BylundEuropean Journal of Pharmacology|October 29, 1985
p-Azidoclonidine: a photoaffinity label for the alpha 2-adrenoceptorR S Kawahara, K H Byington, D B BylundEuropean Journal of Pharmacology|June 30, 2001
Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivityH K Happe, D B Bylund, L C MurrinThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1988
Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtypeD B Bylund, C Ray-Prenger, T J MurphyThe American Journal of Psychiatry|February 1, 1976
The dopamine hypothesis of schizophrenia: focus on the dopamine receptorS H SnyderPageof 67